Pharmacotherapy for obsessive-compulsive
✍
Darin D. Dougherty; Scott L. Rauch; Michael A. Jenike
📂
Article
📅
2004
🏛
John Wiley and Sons
🌐
English
⚖ 69 KB
## Abstract Pharmacotherapeutic options for obsessive‐compulsive disorder (OCD) have expanded over the past half‐century since medications were first found to be effective for the treatment of OCD. Currently, the serotonin reuptake inhibitors (SRIs) represent the first‐line pharmacotherapy for OCD.